Human immunodeficiency virus (HIV-1)-infected subjects with acquired immunodeficiency
syndrome (AIDS) are often infected with multiple pathogens. In particular, HTLV-I and HTLV …

The prevalence and the risk factors of the human T-cell leukemia virus type I/II (HTLV-I/II)
infection were evaluated among 552 individuals at high risk for HIV-1. HTLV infections …

BACKGROUND: The HTLV-II infection has been reported in patients with HIV infection as
often in asymptomatic as those with acquired immunodeficiency syndrome (AIDS). The aim …

Human T-lymphotropic virus type II (HTLV-II) has not yet been associated with any disease.
Little is known about the proviral loads of HTLV-II in vivo and its relationship, if any, to lack of …

A 37 year-old man coinfected with HIV-1 and human T-lymphotropic virus type II presumably
through injection drug use had a high CD4+ count and low HIV viral load without anti …

Background. Human T cell lymphotropic virus type 2 (HTLV-2) infection is not rare among
injection drug users with human immunodeficiency virus (HIV) infection and may exert a …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

HIV, HTLV-1/-2, and HCV share routes of transmission, and such virus co-infections could
account for worse outcomes of associated diseases. Measuring cytokines/chemokines, CD4 …

INTRODUCTION: Apart from masking the diagnosis of AIDS in patients with HIV/AIDS,
human T-cell lymphotropic virus (HTLV), when present, also increases the risk of …

Objectives: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II
infection among HIV-infected women and women at high risk for HIV infection. Design …